Recent years have been a transformational journey for MSD Brinny, with a focus on data, digitalisation and a future primed for remarkable innovation. A €300 million investment since 2018 has heralded ...

Pharma group MSD has joined forces with Owkin to develop artificial intelligence-powered digital pathology diagnostics that could be used to identify patients suitable for immunotherapies. The focus ...

MSD and Verily (formerly Google Life Sciences) are teaming up with NHS England to launch the Long Term Conditions Early Intervention Programme, aimed at evaluating the impact of new technologies in ...

A simple video-based remote care service, and disease-specific mobile apps and wearable technology were among the recipients of an MSD, UK-backed digital healthcare accelerator programme. Velocity ...